NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137 | -85.9% | 8,486 | -63.7% | 0.00% | -83.3% |
| Q2 2023 | $971 | -99.9% | 23,400 | 0.0% | 0.01% | -36.8% |
| Q1 2023 | $1,407,276 | -18.0% | 23,400 | 0.0% | 0.02% | -20.8% |
| Q4 2022 | $1,716,390 | +6.9% | 23,400 | +1.3% | 0.02% | +20.0% |
| Q3 2022 | $1,605,000 | -62.6% | 23,100 | -58.4% | 0.02% | -16.7% |
| Q2 2022 | $4,289,000 | +59.8% | 55,500 | +71.3% | 0.02% | -7.7% |
| Q1 2022 | $2,684,000 | -3.9% | 32,400 | -12.9% | 0.03% | +4.0% |
| Q4 2021 | $2,793,000 | – | 37,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |